HUMANIGEN, INC
DelistedCIK 1293310fmd_0PXE59EVGSEJTTP3T8PN3MZ4SRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2023, 49 periods
Latest annual · FY2022
Millions- Total revenues
- 3
- Operating income
- (68)
- Net income
- (71)
Latest quarter · Q1 FY2023
Millions- Total revenues
- 0
- Operating income
- (4)
- Net income
- (4)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- n/m
- Revenue, 5 yearsFY2017 to FY2022
- n/m
- Net income, 5 yearsFY2017 to FY2022
- n/m
HUMANIGEN, INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.5 million | $3.6 million | -30.1% | 10-K 2023-03-30 · proof |
| Operating income | -$68.3 million | -$232.8 million | 10-K 2023-03-30 · proof | |
| Net income | -$70.7 million | -$236.6 million | 10-K 2023-03-30 · proof | |
| Cash from operating activities | -$76.7 million | -$184 million | 10-K 2023-03-30 · proof | |
| Total assets | $11.2 million | $71.1 million | -84.2% | 10-K 2023-03-30 · proof |
| Total liabilities | $58 million | $94.7 million | -38.8% | 10-K 2023-03-30 · proof |
| Cash and cash equivalents | $10.2 million | $70 million | -85.5% | 10-K 2023-03-30 · proof |
- What was HUMANIGEN, INC's revenue in fiscal 2022?
- HUMANIGEN, INC reported revenue of $2.5 million for fiscal 2022 (the year ended Dec 31, 2022), against $3.6 million the year before (-30.1%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was HUMANIGEN, INC's operating income in fiscal 2022?
- HUMANIGEN, INC reported operating income of -$68.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$232.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was HUMANIGEN, INC's net income in fiscal 2022?
- HUMANIGEN, INC reported net income of -$70.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$236.6 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was HUMANIGEN, INC's cash from operating activities in fiscal 2022?
- HUMANIGEN, INC reported cash from operating activities of -$76.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$184 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are HUMANIGEN, INC's total assets?
- As of Dec 31, 2022, HUMANIGEN, INC reported total assets of $11.2 million, against $71.1 million a year earlier (-84.2%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are HUMANIGEN, INC's total liabilities?
- As of Dec 31, 2022, HUMANIGEN, INC reported total liabilities of $58 million, against $94.7 million a year earlier (-38.8%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are HUMANIGEN, INC's cash and cash equivalents?
- As of Dec 31, 2022, HUMANIGEN, INC reported cash and cash equivalents of $10.2 million, against $70 million a year earlier (-85.5%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1293310&period_type=annual&limit=5"Information only, not investment advice.